Intellia Therapeutics advances in vivo and ex vivo CRISPR/Cas9 genome editing therapies for genetic diseases. Tailored for modern biology and life science teams.
Editas Medicine is developing CRISPR genome editing medicines for ocular, hematologic, and oncologic diseases. Tailored for modern biology and life science teams.
bluebird bio develops gene therapies using lentiviral vectors to treat severe genetic diseases like thalassemia and sickle cell. Tailored for modern biology and life science teams.
Moderna develops mRNA medicines spanning infectious disease, oncology, rare disease, and autoimmune applications. Tailored for modern biology and life science teams.
BioNTech is an immunotherapy company advancing mRNA vaccines, cell therapies, and targeted oncology treatments. Tailored for modern biology and life science teams.
Harvard’s Wyss Institute engineers biologically inspired technologies spanning organ-on-chip, robotics, and regenerative medicine. Tailored for modern biology and life science teams.
